Autoimmune disease patients with comorbid cancer exhibit prominent immunometabolic crosstalk.
Together, these findings define an internally consistent immunometabolic pattern associated with cancer comorbidities in patients with AIDs and nominate amino acid metabolism and CXCL9/Galectin-9-centered immune signaling as candidates for mechanistic investigation and biomarker development, while underscoring the need...